BetterLife Pharma Inc.
corporate_fare Company Profile
BetterLife Pharma Inc. (OTC:BETRF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for BETRF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-30, rated 9/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for BETRF spans 6-K, 20-F.
Recent high-impact activity:
- BetterLife Closes $138.7M Offering, Faces Director Dispute Over $2M Convertible Debenture
- BetterLife Names Migraine Drug Development Veteran as CMO and Raises $531K from Warrant Exercises
- BetterLife Sharpens Focus on Migraine with BETR-001, Adds Board Expertise, and Secures $352,500 from Warrant Exercises
- BetterLife Pharma Reports Worsening Q1 Losses Amid Going Concern Warning; Secures Dilutive Capital
- BetterLife Pharma Secures CAD $2M Insider-Backed Convertible Debenture to Fund BETR-001 IND
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 126,688 shares in BETRF as of the September 15, 2026 settlement, a 57.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 18.1% of BETRF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BETRF, detected from its recent SEC filings · based on capital-structure filings through 2026-06-26.
Increased Net Loss · Going Concern Warning Reiterated
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
BETRF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.